Clinical Trial Update: Adrenal Scans With Radioiodine-Labeled Norcholesterol (NP-59) [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating NP-59 (radioiodinated norcholesterol) for adrenal imaging has completed, focusing on imaging adrenal tumors and related endocrine abnor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adrenal Cancer
• Adrenal Tumors
• Endocrine Disorders

Drugs mentioned

• NP-59 adrenal scan (radioiodinated norcholesterol (NP-59))

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Adrenal Tumors, Adrenal Malignancies | Phase 1 | Status: COMPLETED